Carvedilol Drug Market Size

Carvedilol Drug Market size is poised to witness lucrative growth rate during the forecast period i.e., between 2024-2036. The growth of the market can be attributed to the increasing prevalence of cardiac diseases that result in heart failure, along with the growing cases of hypertension across the globe. Poor lifestyle is prevalent amongst the masses, including high sugar intake, lack of exercise, stressful lifestyle, and consumption of processed food, which is the primary cause of high blood pressure and cardiovascular diseases. According to the statistics by the World Health Organization (WHO), cardiovascular diseases killed 17.9 million people in 2019, which represents 32% of all deaths globally. Along with this, hypertension is another serious disease, which is known to affect over 1.28 billion adults aged 30-79 years worldwide. Carvedilol is only given to clinically stable patients in case of heart failure, as it is a non-selective adrenergic blocker, which cannot be given as a prescription medication. Moreover, the growing incidences of heart failure is also expected to drive the market growth. In addition to this, the carvedilol drug market growth is projected to increase on the back of increasing medical R&D, along with the emergence of new and advanced medical technologies.